STOCKHOLM - 27 January 2026 - Reference is made to the stock exchange
announcement made by Inify Laboratories AB (the "Company") on 12 January 2026
regarding the commencement of the subscription period in a fully guaranteed
repair issue of 2,304,563 new shares (the "Offer Shares") in the Company (the
"Repair Issue"), at an offer price of NOK 3.50 per Offer Share (the "Offer
Price"), with gross proceeds of approximately NOK 8 million.

The subscription period in the Repair Issue expired on 26 January 2026 at 16:30
hours (CET). By the end of the subscription period, the Company had received
valid subscriptions for 1,256,658 Offer Shares in the Repair Issue. The
remaining 1,047,905 Offer Shares have been allocated to the Guarantors (as
defined below).

Monsun AS and Auris AS (the "Guarantors"), companies controlled by the same
owners as the two largest shareholders Gallivant S.à r.l. ("Gallivant") and
Tauri AS ("Tauri"), respectively, have entered into guarantee undertakings (the
"Guarantee Commitment") covering in total 100% of the Repair Issue and the
preceding private placement (the "Private Placement"). The Guarantors will not
receive any compensation for the Guarantee Commitment.

The Company's board of directors has resolved to allocate 2,304,563 Offer Shares
at the Offer Price, in accordance with the allocation criteria set out in the
subscription form for the Repair Issue, raising gross proceeds of NOK
8,065,970.50. 1,256,658 Offer Shares were allocated to Eligible Shareholders (as
defined in the subscription form), and the remaining 1,047,905 Offer Shares were
allocated to the Guarantors of the Repair Issue, as follows:

-          Monsun AS: 898,204 Offer Shares

-          Auris AS: 149,701 Offer Shares

Notifications of allocated Offer Shares and the corresponding amount to be paid
by each subscriber are expected to be distributed on or about 28 January 2026.
The Offer Shares were issued by the extraordinary general meeting of the Company
held on 4 December 2025. The due date for payment of the Offer Shares is on or
about 25 March 2026. Subject to timely payment of the Offer Shares subscribed
for and allocated in the Repair Issue, and subject to registration of the
capital increase pertaining to the Repair Issue with the Swedish Companies
Registration Office (Sw.: Bolagsverket), the delivery of the Offer Shares is
expected to take place on or about 30 March 2026. The Offer Shares are expected
to commence trading on Euronext Growth Oslo on or about 30 March 2026.

Advisors

SB1 Markets AS ("SB1 Markets") has been appointed as financial advisor in
connection with the Private Placement and the Repair Issue. Schjødt law firm
acts as legal counsel to the Company.

For further information, please contact CEO, Fredrik Palm,
fredrik.palm@inify.com, or visit https://www.inify.com

###

The future of diagnostics

Inify Laboratories offers diagnostics through specialised laboratory services in
histopathology, with a focus on streamlining patient pathways. The company
performs clinical diagnostics in prostate cancer and gastroenterology, providing
an integrated service that spans from early sample handling to final diagnosis.
The laboratory system is scalable both in handling large volumes of patient
samples and for replicating in new locations.

Quality and response times are optimised in every step - from logistics to
tissue preparation and diagnosis - using a fully digital, standardised and AI
-assisted workflow. The diagnosis is always performed by a pathologist and is
assisted by Inify's proprietary AI, proven to have world-leading precision in
clinical evaluations. The entire workflow is supported by a tailor-made system
that also enables development to include additional diagnostic areas.

Inify Laboratories is an international group headquartered in Stockholm, Sweden,
with local laboratories in Sweden and the UK. The company's share is listed on
Euronext Growth Oslo (https://live.euronext.com/en/product/equities/SE0017486103
-MERK) under the ticker
INIFY. (https://live.euronext.com/en/product/equities/SE0017486103-MERK)

###

This information is subject to the disclosure requirements pursuant to section 5
-12 the Norwegian Securities Trading Act.

Important information

The release, announcement or distribution of this press release may, in certain
jurisdictions, be subject to restrictions. The recipients of this press release
in jurisdictions where this press release has been published or distributed
shall inform themselves of and follow such restrictions. The recipient of this
press release is responsible for using this press release, and the information
contained herein, in accordance with applicable rules in each jurisdiction. The
information in this press release does not contain or constitute an offer to
acquire, subscribe or otherwise trade in shares, subscription rights or other
securities in the Company in any jurisdiction.

This press release does not identify or suggest, or purport to identify or
suggest, the risks (direct or indirect) that may be associated with an
investment in new shares. Any investment decision in connection with the Private
Placement and the Repair Issue must be made on the basis of all publicly
available information relating to the Company and the Company's shares. Such
information has not been independently verified by SB1 Markets. The information
contained in this announcement is for background purposes only and does not
purport to be full or complete. No reliance may be placed for any purpose on the
information contained in this announcement or its accuracy or completeness. SB1
Markets is acting for the Company in connection with the transaction and no one
else and will not be responsible to anyone other than the Company for providing
the protections afforded to its clients nor for giving advice in relation to the
transaction or any other matter referred to herein.

This press release does not constitute a recommendation concerning any
investor's option with respect to the Private Placement and the Repair Issue.
Each investor or prospective investor should conduct his, her or its own
investigation, analysis and evaluation of the business and data described in
this announcement and publicly available information. The price and value of
securities can go down as well as up. Past performance is not a guide to future
performance.

The information contained in this press release is not intended for, and must
not be accessed by, or distributed or disseminated, directly or indirectly, in
whole or in part, to persons resident or physically present in the United States
of America (including its territories and possessions, any state of the United
States and the District of Columbia) (the "United States"), Australia, Canada,
Hong Kong, Japan, New Zealand, Singapore, South Africa, United Kingdom or any
other jurisdiction where such action is wholly or partially subject to legal
restrictions, or would require additional prospectuses, registration or other
measures than those required by Norwegian law. The information in the press
release does not constitute any offer regarding subscription rights, paid
subscribed shares or shares in the Company ("Securities") to any person in said
jurisdictions. The information in the press release may not be forwarded or
reproduced in such a manner that contravenes such restrictions or gives cause to
such requirements.

No securities have been or will be registered under the United States Securities
Act of 1933, as amended (the "Securities Act") or the securities legislation of
any state or other jurisdiction in the United States and may not be offered,
subscribed for, exercised, used, pledged, sold, resold, granted, delivered or
otherwise transferred, directly or indirectly, in or into the United States
except pursuant to an applicable exemption from, or in a transaction not subject
to, the registration requirements under the Securities Act and in compliance
with the securities legislation in the relevant state or any other jurisdiction
of the United States.

Within the European Economic Area ("EEA"), no public offering of Securities is
made in other countries than Sweden or Norway. In other member states of the EU,
such an offering of Securities may only be made in accordance with the
Prospectus Regulation (EU) 2017/1129 (the "Prospectus Regulation"). In other
member states of the EEA which have implemented the Prospectus Regulation in its
national legislation, any offer of Securities may only be made in accordance
with an applicable exemption in the Prospectus Regulation and/or in accordance
with an applicable exemption under a relevant national implementation measure.

In the United Kingdom, this document and any other materials in relation to the
securities described herein is only being distributed to, and is only directed
at, and any investment or investment activity to which this document relates is
available only to, and will be engaged in only with, "qualified investors" who
are (i) persons having professional experience in matters relating to
investments who fall within the definition of "investment professionals" in
Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 (the "Order")